A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure.

A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension

NCT00219050 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine

NCT00219154 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.

NCT00219063 ·Status: COMPLETED ·Phase: PHASE3

Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension

NCT00219037 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension

NCT00739973 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients

NCT00219193 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled Study

NCT00706134 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders Patients

NCT00219076 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension

NCT00765947 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients

NCT01042392 ·Status: COMPLETED ·Phase: PHASE4

Effect of High and Low Sodium Diets on Blood Pressure in Hypertensive Patients Treated With Aliskiren

NCT00441064 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age

NCT01150357 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension

NCT00424541 ·Status: COMPLETED ·Phase: PHASE1

Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension

NCT00219141 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension

NCT00705575 ·Status: COMPLETED ·Phase: PHASE3

Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine

NCT01113047 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension

NCT00344110 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine

NCT00294710 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate Hypertension

NCT00262236 ·Status: COMPLETED ·Phase: PHASE3

SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction

NCT00299832 ·Status: COMPLETED ·Phase: PHASE3

Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension

NCT00797316 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise

NCT00819767 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension

NCT00867490 ·Status: COMPLETED ·Phase: PHASE3

Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population

NCT00760266 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients

NCT00219102 ·Status: COMPLETED ·Phase: PHASE3